Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Why is Daiichi Sankyo stock falling today?

  • Daiichi Sankyo and Merck withdraw lung cancer treatment application in US.
  • FDA rejects mid-stage clinical study data for ifinatamab deruxtecan.
  • Second rejection for co-developed therapies by the companies.

Why is Nidec stock plunging today?

  • Nidec stock drops 17.6% to ¥2,340, hitting daily downside limit
  • Japanese outlet reports ¥1 trillion ($6.3 billion) impairment charge
  • Nidec board removes CEO Mitsuya Kishida in emergency session

More from Monday 28 September →